ES2157148B1 - Nuevas piperidinas 4-sustituidas. - Google Patents

Nuevas piperidinas 4-sustituidas.

Info

Publication number
ES2157148B1
ES2157148B1 ES009802420A ES9802420A ES2157148B1 ES 2157148 B1 ES2157148 B1 ES 2157148B1 ES 009802420 A ES009802420 A ES 009802420A ES 9802420 A ES9802420 A ES 9802420A ES 2157148 B1 ES2157148 B1 ES 2157148B1
Authority
ES
Spain
Prior art keywords
new
substituted
sub
compounds
piperidins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES009802420A
Other languages
English (en)
Other versions
ES2157148A1 (es
Inventor
Venero Aurelio Orjales
Avello Antonio Toledo
Duran Carmen Pumar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Faes Farma SA
Original Assignee
Fabrica Espanola de Productos Quimicos y Farmaceuticos FAES SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fabrica Espanola de Productos Quimicos y Farmaceuticos FAES SA filed Critical Fabrica Espanola de Productos Quimicos y Farmaceuticos FAES SA
Priority to ES009802420A priority Critical patent/ES2157148B1/es
Priority to CA002288533A priority patent/CA2288533C/en
Priority to HU9904086A priority patent/HU227558B1/hu
Priority to ARP990105657A priority patent/AR028805A1/es
Priority to DK99500208T priority patent/DK1002794T3/da
Priority to AT99500208T priority patent/ATE422199T1/de
Priority to DE69940378T priority patent/DE69940378D1/de
Priority to EP99500208A priority patent/EP1002794B1/en
Priority to IL13286299A priority patent/IL132862A0/xx
Priority to ES99500208T priority patent/ES2323742T3/es
Priority to CZ19993995A priority patent/CZ296053B6/cs
Priority to PT99500208T priority patent/PT1002794E/pt
Priority to AU59366/99A priority patent/AU757177B2/en
Priority to HR990354A priority patent/HRP990354B1/xx
Priority to NO19995643A priority patent/NO314401B1/no
Priority to PL336607A priority patent/PL196329B1/pl
Priority to BRPI9905634-8A priority patent/BR9905634B1/pt
Priority to KR1019990051053A priority patent/KR100646675B1/ko
Priority to TR1999/02839A priority patent/TR199902839A3/tr
Priority to RU99124412/04A priority patent/RU2232753C2/ru
Priority to JP32888599A priority patent/JP4667552B2/ja
Priority to US09/824,189 priority patent/US6518284B2/en
Publication of ES2157148A1 publication Critical patent/ES2157148A1/es
Application granted granted Critical
Publication of ES2157148B1 publication Critical patent/ES2157148B1/es
Priority to CY20091100388T priority patent/CY1108955T1/el
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/12—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with only hydrogen atoms attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Nuevas piperidinas 4-sustituidas. Se describen nuevas piperidinas-4 sustituidas de fórmula general (I), donde R{sub, 1}, y R{sub, 2} son radicales arilo, sustituidos o sin sustituir, y que son obtenidas como mezclas racémicas y como enantiómeros puros. **FORMULA** . Estos compuestos, y sus sales farmacéuticamente aceptables, inhiben la recaptación de serotonina y/o noradrenalina, siendo de utilidad como antidepresivos. Otras posibles aplicaciones terapéuticas de estos compuestos son el tratamiento de la bulimia nerviosa, los desórdenes obsesivo-compulsivos, la adicción al alcohol, la ansiedad, el pánico, el dolor, el síndrome premenstrual y la fobia social, así como la profilaxis de la migraña.
ES009802420A 1998-11-18 1998-11-18 Nuevas piperidinas 4-sustituidas. Expired - Fee Related ES2157148B1 (es)

Priority Applications (23)

Application Number Priority Date Filing Date Title
ES009802420A ES2157148B1 (es) 1998-11-18 1998-11-18 Nuevas piperidinas 4-sustituidas.
CA002288533A CA2288533C (en) 1998-11-18 1999-11-04 New 4-substituted piperidines
HU9904086A HU227558B1 (en) 1998-11-18 1999-11-08 4-substituted piperidine derivatives and pharmaceutical compositions containing them
ARP990105657A AR028805A1 (es) 1998-11-18 1999-11-09 Nuevas piperidinas 4-sustituidas, asi como sus sales farmaceuticas con acidos inoranicos y organicos, obtenidas como mezclas racemicas y como enantiomeros puros, mezclados con excipientes para administracion oral, parental y topica
DK99500208T DK1002794T3 (da) 1998-11-18 1999-11-10 4-(aryl)(aryloxy)methylpiperidinderivater og anvendelse deraf som serotonin og/eller noradrenalingenoptagelsesinhibitorer
DE69940378T DE69940378D1 (de) 1998-11-18 1999-11-10 4-i(Aryl)(aryloxy)methyl piperidinderivate und ihre Verwendung als Serotonin und/oder Noradrenalin Reuptake Inhibitoren
EP99500208A EP1002794B1 (en) 1998-11-18 1999-11-10 4-¬(Aryl)(aryloxy)methyl piperidine derivatives and their use as serotonin and/or noradrenaline reuptake inhibitors
IL13286299A IL132862A0 (en) 1998-11-18 1999-11-10 New 4-substituted piperidines
ES99500208T ES2323742T3 (es) 1998-11-18 1999-11-10 Derivados de 4-(aril)(ariloxi)metil piperidina y su uso como inhibidores de la recaptacion de serotonina y/o noradrenalina.
CZ19993995A CZ296053B6 (cs) 1998-11-18 1999-11-10 4-Substituované piperidiny
PT99500208T PT1002794E (pt) 1998-11-18 1999-11-10 Derivados de 4-(aril)(aroloxi)metilpiperidina e sua utilização como inibidores da reabsorção da serotonina e/ou noradrenalina
AT99500208T ATE422199T1 (de) 1998-11-18 1999-11-10 4- (aryl)(aryloxy)methyl piperidinderivate und ihre verwendung als serotonin und/oder noradrenalin reuptake inhibitoren
AU59366/99A AU757177B2 (en) 1998-11-18 1999-11-11 New 4-substituted piperidines
HR990354A HRP990354B1 (en) 1998-11-18 1999-11-16 New 4-substituted piperidines
RU99124412/04A RU2232753C2 (ru) 1998-11-18 1999-11-17 4-замещенные пиперидины, фармацевтическая композиция на их основе и способ лечения заболеваний центральной нервной системы
BRPI9905634-8A BR9905634B1 (pt) 1998-11-18 1999-11-17 piperidinas 4-substituìdas.
KR1019990051053A KR100646675B1 (ko) 1998-11-18 1999-11-17 신규의 4-치환된 피페리딘
TR1999/02839A TR199902839A3 (tr) 1998-11-18 1999-11-17 Yeni 4-ikameli piperidinler.
NO19995643A NO314401B1 (no) 1998-11-18 1999-11-17 Nye, 4-substituerte piperidiner, farmasöytisk preparat inneholdende disse og anvendelse av dem for fremstilling av et medikament
PL336607A PL196329B1 (pl) 1998-11-18 1999-11-17 4-podstawione piperydyny, kompozycja farmaceutyczna zawierająca takie związki oraz zastosowanie
JP32888599A JP4667552B2 (ja) 1998-11-18 1999-11-18 新規な４−置換ピペリジン
US09/824,189 US6518284B2 (en) 1998-11-18 2001-04-02 4-substituted piperidines
CY20091100388T CY1108955T1 (el) 1998-11-18 2009-04-02 Παραγωγα 4-(αρυλ)-(αρυλοξυ)μεθυλοπιπεριδινης και η χρηση τους ως αναστολεις επαναπροσληψης σεροτονινης και/ή νοραδρεναλινης

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009802420A ES2157148B1 (es) 1998-11-18 1998-11-18 Nuevas piperidinas 4-sustituidas.

Publications (2)

Publication Number Publication Date
ES2157148A1 ES2157148A1 (es) 2001-08-01
ES2157148B1 true ES2157148B1 (es) 2002-03-01

Family

ID=8305832

Family Applications (2)

Application Number Title Priority Date Filing Date
ES009802420A Expired - Fee Related ES2157148B1 (es) 1998-11-18 1998-11-18 Nuevas piperidinas 4-sustituidas.
ES99500208T Expired - Lifetime ES2323742T3 (es) 1998-11-18 1999-11-10 Derivados de 4-(aril)(ariloxi)metil piperidina y su uso como inhibidores de la recaptacion de serotonina y/o noradrenalina.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES99500208T Expired - Lifetime ES2323742T3 (es) 1998-11-18 1999-11-10 Derivados de 4-(aril)(ariloxi)metil piperidina y su uso como inhibidores de la recaptacion de serotonina y/o noradrenalina.

Country Status (21)

Country Link
EP (1) EP1002794B1 (es)
JP (1) JP4667552B2 (es)
KR (1) KR100646675B1 (es)
AR (1) AR028805A1 (es)
AT (1) ATE422199T1 (es)
AU (1) AU757177B2 (es)
BR (1) BR9905634B1 (es)
CA (1) CA2288533C (es)
CY (1) CY1108955T1 (es)
CZ (1) CZ296053B6 (es)
DE (1) DE69940378D1 (es)
DK (1) DK1002794T3 (es)
ES (2) ES2157148B1 (es)
HR (1) HRP990354B1 (es)
HU (1) HU227558B1 (es)
IL (1) IL132862A0 (es)
NO (1) NO314401B1 (es)
PL (1) PL196329B1 (es)
PT (1) PT1002794E (es)
RU (1) RU2232753C2 (es)
TR (1) TR199902839A3 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2485355A1 (en) * 2002-05-30 2003-12-11 Head Explorer A/S The use of milnacipran for the treatment of tension-type headache
UA77536C2 (en) * 2002-07-03 2006-12-15 Lundbeck & Co As H Secondary aminoaniline piperidines as mch1 antagonists and their use
ATE471320T1 (de) 2004-02-27 2010-07-15 Lilly Co Eli 4-aminopiperidinderivate als inhibitoren der monoamin-aufnahme
WO2006009831A1 (en) 2004-06-18 2006-01-26 Wyeth Processes for preparing 6-alkyl-5-arylsulfonyl- dihydrophenanthridines
EP1854785A1 (en) * 2006-05-12 2007-11-14 Faes Farma, S.A. 4-[(3-fluorophenoxy)phenylmethyl]piperidine methanesulfonate: uses, process of synthesis and pharmaceutical compositions
US20100120858A1 (en) * 2006-08-23 2010-05-13 Pfizer Inc. Piperidine Derivatives
JP5529150B2 (ja) * 2008-11-14 2014-06-25 セラヴァンス， インコーポレーテッド ４−［２−（２−フルオロフェノキシメチル）フェニル］ピペリジン化合物
US20100267743A1 (en) * 2009-04-15 2010-10-21 Stangeland Eric L 3-(phenoxypyrrolidin-3-yl-methyl)heteroaryl, 3-(phenylpyrrolidin-3-ylmethoxy)heteroaryl, and 3-(heteroarylpyrrolidin-3-ylmethoxy)heteroaryl compounds
BR112012029815A2 (pt) 2010-05-24 2017-03-07 Faes Farma Sa derivados de flufenoxina pra o tratamento e prevenção de patologias amiloides
EP2390248A1 (en) 2010-05-24 2011-11-30 Faes Farma, S.A. Flufenoxine derivatives for the treatment and prevention of amiloyd pathologies

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1203149A (en) * 1968-06-10 1970-08-26 Ici Ltd Piperidine derivatives
JPH0615529B2 (ja) * 1985-04-01 1994-03-02 エーザイ株式会社 新規ピペリジン誘導体
JPH0840999A (ja) * 1994-08-04 1996-02-13 Yamanouchi Pharmaceut Co Ltd フルオロインダン誘導体
CO5150201A1 (es) * 1998-09-07 2002-04-29 Hoffmann La Roche Derivados de piperidina

Also Published As

Publication number Publication date
PT1002794E (pt) 2009-03-25
NO995643D0 (no) 1999-11-17
CZ399599A3 (cs) 2000-08-16
BR9905634B1 (pt) 2012-09-04
NO314401B1 (no) 2003-03-17
EP1002794A1 (en) 2000-05-24
AU757177B2 (en) 2003-02-06
JP4667552B2 (ja) 2011-04-13
DE69940378D1 (de) 2009-03-19
TR199902839A2 (xx) 2000-09-21
HUP9904086A3 (en) 2001-11-28
HU9904086D0 (en) 2000-01-28
NO995643L (no) 2000-05-19
ES2323742T3 (es) 2009-07-23
IL132862A0 (en) 2001-03-19
JP2000154176A (ja) 2000-06-06
CZ296053B6 (cs) 2005-12-14
CY1108955T1 (el) 2014-07-02
RU2232753C2 (ru) 2004-07-20
ATE422199T1 (de) 2009-02-15
HRP990354A2 (en) 2000-06-30
DK1002794T3 (da) 2009-04-14
HRP990354B1 (en) 2008-11-30
KR100646675B1 (ko) 2006-11-17
CA2288533A1 (en) 2000-05-18
KR20000035525A (ko) 2000-06-26
TR199902839A3 (tr) 2000-09-21
HUP9904086A2 (hu) 2000-11-28
AU5936699A (en) 2000-05-25
HU227558B1 (en) 2011-08-29
PL336607A1 (en) 2000-05-22
AR028805A1 (es) 2003-05-28
ES2157148A1 (es) 2001-08-01
PL196329B1 (pl) 2007-12-31
CA2288533C (en) 2009-01-06
EP1002794B1 (en) 2009-02-04
BR9905634A (pt) 2000-09-26

Similar Documents

Publication Publication Date Title
EA200400498A1 (ru) Производные фенилпиперазина как ингибиторы обратного захвата серотонина
ES2157148B1 (es) Nuevas piperidinas 4-sustituidas.
EA200401282A1 (ru) Пиридиноилпиперидины как агонисты 5-ht1f
CY1109225T1 (el) ΠΑΡΑΓΩΓΑ ΜΗΛΟΝΑΜΙΔΙΟΥ ΤΑ ΟΠΟΙΑ ΠΑΡΕΜΠΟΔΙΖΟΥΝ ΤΗ ΔΡΑΣΗ ΤΗΣ γ-ΣΕΚΡΕΤΑΣΗΣ
ECSP066405A (es) Compuestos de aril o heteroaril amida
ATE13422T1 (de) Derivate von 1-aryl-2-aminomethyl-cyclopropancarboxamiden (z), ihre herstellung und ihre verwendung fuer die behandlung von stoerungen des zentralnervensystems.
MX9307332A (es) 3-(aminoalquilamino)-1,2-bencisoxasoles substituidos y compuestos relacionados.
ATE362931T1 (de) 8-azabicyclo(3.2.1)oct-2en-derivate, deren herstellung und anwendung
PE20060689A1 (es) Derivados de sulfonamidas como antagonistas de receptores orexina 2
PE20030040A1 (es) Compuestos aromaticos heterobiciclicos sustituidos con quinuclinida para el tratamiento de patologias
HRP20080262T3 (en) 4-(2-phenyloxyphenyl)-piperidine or -1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors
EA200600061A1 (ru) Бензамиды 4-(аминометил) пиперидина как 5нт-антагонисты
ES2038202T3 (es) Derivados de alcanos trifluorometil insecticidos.
ATE302747T1 (de) Verfahren zur herstellung von amphetaminen aus phenylpropanolaminen
BR0208812A (pt) Derivados fenil heterociclil éter como inibidores de recaptação de serotonina
DE60201829D1 (de) Azaheterocyclylmethyl derivative des 2,3-dihydro-1,4-dioxino(2,3-f)quinolins als antidepressiva
AR041898A1 (es) Derivados de 4(fenil-piperazinil-metil) benzamida y sus usos para el tratamiento del dolor y desordenes gastrointestinales
EA200501579A1 (ru) Производные 4-(2-фенилсульфанилфенил)-1,2,3,6-тетрагидропиридина в качестве ингибиторов повторного поглощения серотонина
ATE312094T1 (de) Neue heteroarylderivate, deren herstellung und verwendung
NO20050612L (no) Pyrrolidinderivater som oksytocinantagonister
ATE248147T1 (de) Piperidine derivate als inhibitoren der neurotransmitter-wiederaufbaunahme
ATE372332T1 (de) Verfahren zur herstellung von zwischenverbindungen in der herstellung von discodermolid und discodermolid-analoga
UA81469C2 (en) 4-(2-phenyloxyphenyl)-piperidine or -1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors
EA200400104A1 (ru) Новые производные индола
AR042554A1 (es) Benzodioxepinas sustituidas

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20010801

Kind code of ref document: A1

Effective date: 20010801

GC2A Exploitation certificate registered application with search report

Effective date: 20070806

FD2A Announcement of lapse in spain

Effective date: 20180807